Plus Therapeutics Presents Positive CNSide CSF Assay Platform Results at the 2025 SNO/ASCO CNS Metastases Conference
PLSTCNSide® can quantify leptomeningeal metastases (LM) over time and monitor changes in the expression of multiple targetable mutations
August 14, 2025Clinical
Read more →